Lung Cancer Trial, Recruiting NCT06669104 Sponsor: Chinese University of Hong Kong Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06669104
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 80 years of age
  • People with a body mass index (a measure of body weight relative to height) below 35
  • People whose condition is suitable for a type of surgery that uses small incisions rather than large cuts (minimally invasive surgery)
  • People who are willing to take part and have signed a consent form

Who may not be able to join:

  • People for whom general anaesthesia (being fully asleep during surgery) is not safe or recommended
  • People with a serious ongoing illness that significantly shortens life expectancy or makes the risks of treatment too high
  • People with an active infection that has not yet been treated
  • People with a blood-clotting disorder that cannot be corrected
  • People who need emergency surgery
  • People in vulnerable groups, such as those with an intellectual disability or who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Calvin Sze Hang Ng, CUHK

Phone: 85235052629

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
31 August 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

The conversion rate; The peri-operative complication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov